» Articles » PMID: 37839919

Surviving Sepsis After Burn Campaign

Abstract

Introduction: The Surviving Sepsis Campaign was developed to improve outcomes for all patients with sepsis. Despite sepsis being the primary cause of death after thermal injury, burns have always been excluded from the Surviving Sepsis efforts. To improve sepsis outcomes in burn patients, an international group of burn experts developed the Surviving Sepsis After Burn Campaign (SSABC) as a testable guideline to improve burn sepsis outcomes.

Methods: The International Society for Burn Injuries (ISBI) reached out to regional or national burn organizations to recommend members to participate in the program. Two members of the ISBI developed specific "patient/population, intervention, comparison and outcome" (PICO) questions that paralleled the 2021 Surviving Sepsis Campaign [1]. SSABC participants were asked to search the current literature and rate its quality for each topic. At the Congress of the ISBI, in Guadalajara, Mexico, August 28, 2022, a majority of the participants met to create "statements" based on the literature. The "summary statements" were then sent to all members for comment with the hope of developing an 80% consensus. After four reviews, a consensus statement for each topic was created or "no consensus" was reported.

Results: The committee developed sixty statements within fourteen topics that provide guidance for the early treatment of sepsis in burn patients. These statements should be used to improve the care of sepsis in burn patients. The statements should not be considered as "static" comments but should rather be used as guidelines for future testing of the best treatments for sepsis in burn patients. They should be updated on a regular basis.

Conclusion: Members of the burn community from the around the world have developed the Surviving Sepsis After Burn Campaign guidelines with the goal of improving the outcome of sepsis in burn patients.

Citing Articles

Insights into bloodstream infections in South African paediatric burn patients: implications for antimicrobial stewardship.

Christie M, Avenant T, Nembudani M, Mnqandi A, Muller C, de Villiers M BMC Infect Dis. 2025; 25(1):362.

PMID: 40087547 DOI: 10.1186/s12879-025-10582-6.


Profiling of miRNAs Contained in Circulating Extracellular Vesicles and Associated with Sepsis Development in Burn Patients: A Proof-of-Concept Study.

Schiavello M, Bosco O, Vizio B, Sciarrillo A, Pensa A, Pivetta E Int J Mol Sci. 2025; 26(5).

PMID: 40076471 PMC: 11899136. DOI: 10.3390/ijms26051844.


Early Detection, Diagnosis, Prevention, and Treatment of Infection to Avoid Sepsis and Septic Shock in Severely Burned Patients: A Narrative Review.

Honore P, Blackman S, Perriens E, de Schoutheete J, Jennes S Eur Burn J. 2025; 6(1).

PMID: 39982339 PMC: 11843831. DOI: 10.3390/ebj6010006.


High early incidence of sepsis and its impact on organ dysfunction in burn trauma patients: a detailed and hypothesis generating study.

Sjoberg F, Greenhalgh D, Elmasry M, Abdelrahman I, El-Serafi A, Steinvall I Burns Trauma. 2025; 13:tkae085.

PMID: 39931388 PMC: 11808796. DOI: 10.1093/burnst/tkae085.


Procalcitonin in the Post-Operative Burn Patient.

Masole L, Ede C, Muganza A Eur Burn J. 2024; 4(4):596-604.

PMID: 39600028 PMC: 11571844. DOI: 10.3390/ebj4040040.